0001123292-24-000308.txt : 20241017 0001123292-24-000308.hdr.sgml : 20241017 20241017172429 ACCESSION NUMBER: 0001123292-24-000308 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241017 DATE AS OF CHANGE: 20241017 EFFECTIVENESS DATE: 20241017 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Precision Neuroscience Corp CENTRAL INDEX KEY: 0001858288 ORGANIZATION NAME: IRS NUMBER: 862458440 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-527140 FILM NUMBER: 241378418 BUSINESS ADDRESS: STREET 1: 54 W. 21ST ST. STREET 2: SUITE 310 CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 646-771-5881 MAIL ADDRESS: STREET 1: 54 W. 21ST ST. STREET 2: SUITE 310 CITY: NEW YORK STATE: NY ZIP: 10010 D 1 primary_doc.xml X0708 D LIVE 0001858288 Precision Neuroscience Corp 54 W. 21st St. Suite 301 NEW YORK NY NEW YORK 10010 646-771-5881 DELAWARE None None Corporation true 2020 Michael Mager 54 W. 21st St. Suite 301 NEW YORK NY NEW YORK 10010 Director Executive Officer Chief Executive Officer Benjamin Rapoport 54 W. 21st St. Suite 301 NEW YORK NY NEW YORK 10010 Director Executive Officer President, Chief Science Officer Craig Mermel 54 W. 21st St. Suite 301 NEW YORK NY NEW YORK 10010 Director Executive Officer President and Chief Product Officer Jason Chen 54 W. 21st St. Suite 301 NEW YORK NY NEW YORK 10010 Director Ravi Mehta 54 W. 21st St. Suite 301 NEW YORK NY NEW YORK 10010 Director Eric M. Attias 54 W. 21st St. Suite 301 NEW YORK NY NEW YORK 10010 Director Howard Morgan 54 W. 21st St. Suite 301 NEW YORK NY NEW YORK 10010 Director MIchael Kaswan 54 W. 21st St. Suite 301 NEW YORK NY NEW YORK 10010 Executive Officer Chief Financial Officer Other Health Care Decline to Disclose 06b false 2024-10-02 false true true Convertible Securities Shares false 0 150000000 93118915 56881085 false 21 0 0 0 false Precision Neuroscience Corp /s/ Michael Mager Michael Mager Chief Executive Officer 2024-10-17